Protecting American Innovation Act

Bill: 117-hr-7430
Sponsor: Rep. Smith, Adrian [R-NE-3]
Introduced: 2022-04-06 in the House
Policy area: Foreign Trade and International Finance
Subjects: Asia
Cardiovascular and respiratory health
China
Competitiveness, trade promotion, trade deficits
Congressional oversight
Emergency medical services and trauma care
Employee performance
Europe
Federal officials
Foreign aid and international relief
Government ethics and transparency, public corruption
Government information and archives
Government studies and investigations
Health care coverage and access
Health technology, devices, supplies
Immunology and vaccination
Infectious and parasitic diseases
Intellectual property
Legislative rules and procedure
Manufacturing
Medical research
Presidents and presidential powers, Vice Presidents
Public participation and lobbying
Research and development
Russia
Trade agreements and negotiations
World health

Summary:
action_date: 2022-04-06
text: 

Protecting American Innovation Act

 
This bill establishes certain limitations on modifying trade agreements, including those related to the TRIPS Agreement (i.e., the Agreement on Trade-Related Aspects of Intellectual Property Rights). The TRIPS Agreement contains obligations for World Trade Organization members to protect patents and other intellectual property rights.
 
Specifically, the bill prohibits the President (or any U.S. official, employee, or agent) from negotiating or concluding any withdrawal, suspension, or modification to a trade agreement that adversely affects the rights of the United States or U.S. persons under a trade agreement with China or Russia.
 
Additionally, the bill states that a TRIPS waiver to address the COVID-19 pandemic shall not take effect if (1) the President does not submit required reports from the Department of Commerce and the Department of Defense (DOD), (2) the Commerce report concludes that the TRIPS waiver will not result in an increase in global vaccine access, or (3) the DOD report concludes that the TRIPS waiver would adversely impact U.S. national security.
 
Prior to entering into a negotiation with a trading partner concerning a suspension of or modification to a trade agreement, the bill requires (1) the U.S. Trade Representative to publish certain information in the Federal Register and allow for public comment, and (2) the President to provide written notice and consult with Congress. Further, the President shall not enter into any suspension of or modification to a trade agreement unless the President has complied with such consultation requirements and receives congressional approval.


Legislative actions:
action_date: 2022-04-06
text: Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2022-04-06
text: Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2022-04-06
text: Introduced in House
action_date: 2022-04-06
text: Introduced in House